{"slug":"diseases","open_questions":[{"id":"open_question-c5fae337-6322-40ce-8f30-84c5a4b44403","title":"How does cell-to-cell transmission differ between sporadic and genetic forms of PD?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-2b200597-20fa-47d4-bb9a-0832b4162507","title":"What is the therapeutic window for [LRRK2](/entities/lrrk2) kinase inhibition in PD patients?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-c472a9ec-c924-4ed6-9d86-e17ee219ee8c","title":"What are the optimal timing windows for disease-modifying interventions?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-661a6e00-d2cc-4205-a584-85d5caa59800","title":"What is the relationship between sleep disorders and PD pathogenesis?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-fb8cb18c-d027-4ec3-b4da-e070ee7489f6","title":"How does intestinal permeability affect alpha-synuclein aggregation?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-a6da4a2c-7419-4579-bfcf-7c69551a5784","title":"How can biomarker-defined subtypes guide personalized treatment?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-6989b61e-efe5-4f7f-ab8a-440af0791a22","title":"How can biomarker-defined subtypes guide personalized treatment?**: Emerging data suggests different therapeutic responses based on biomarker profiles (e.g., tau burden, APOE status). How should treat","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-1798a058-ba71-4bf2-9a42-e0ec9628c0af","title":"What mechanisms drive severe sleep-disordered breathing and stridor progression in high-risk patients?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-00da591c-d299-4e91-8c48-34cdb7da5656","title":"How should combination therapies balance anti-aggregation, mitochondrial, and anti-inflammatory targets in MSA?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-d10af2df-2f00-4a90-9bc7-8fa615418b0e","title":"What patient-centered endpoints best capture autonomic and quality-of-life benefit beyond motor scales?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-diseases-huntingtons-669ca092","title":"Gene silencing","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-diseases-huntingtons-8f13d270","title":"Aggregation inhibitors","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-diseases-huntingtons-7943a8b2","title":"Neuroprotective","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-diseases-post-covid-neurological-syndrome-6ee76384","title":"Biomarker-guided therapy","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-diseases-psp-non-western-populations-90bd5e9e","title":"Clinical phenotype documentation","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-diseases-psp-non-western-populations-bf1f1258","title":"Healthcare access research","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-7b3f31ee-de65-4346-a7e4-e439a3ac1b3f","title":"How does progranulin insufficiency alter lysosomal and immune function in vulnerable cortical networks?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-470a6f62-050f-495f-bd5a-88a7256539a9","title":"Why oligodendrocytes?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-ea6b51f1-c30e-41e7-a9eb-ed463c444063","title":"What is the precise sequence of events in preclinical AD?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-e7960392-04d0-49e3-bb13-3dcf5c229f4c","title":"Propagation mechanisms**: Can we determine the cell-to-cell transmission pathways for alpha-synuclein in MSA? Can we block them therapeutically?","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5}],"open_questions_total":20,"knowledge_gaps":[],"gap_count":0,"landscape":null,"hypothesis_count":0,"personas":[{"id":"theorist","name":"Theorist","type":"debater","icon":"🧠","color":"#4fc3f7","debate_count":438},{"id":"skeptic","name":"Skeptic","type":"debater","icon":"⚠️","color":"#ffd54f","debate_count":437},{"id":"domain_expert","name":"Domain Expert","type":"debater","icon":"💊","color":"#81c784","debate_count":421},{"id":"synthesizer","name":"Synthesizer","type":"analyst","icon":"📊","color":"#ce93d8","debate_count":381},{"id":"clinical_trialist","name":"Clinical Trialist","type":"reviewer","icon":"📋","color":"#4dd0e1","debate_count":20},{"id":"computational_biologist","name":"Computational Biologist","type":"analyst","icon":"🧬","color":"#7986cb","debate_count":18},{"id":"ethicist","name":"Ethicist","type":"reviewer","icon":"⚖️","color":"#f48fb1","debate_count":8},{"id":"hongkui-zeng","name":"Hongkui Zeng","type":"debater","icon":"🧬","color":"#66bb6a","debate_count":7},{"id":"medicinal_chemist","name":"Medicinal Chemist","type":"builder","icon":"🧪","color":"#aed581","debate_count":7}]}